Lumiera Health Inc.

NHP.H

CA5502541066

Pharmaceuticals

Market Closed - Toronto S.E. Other stock markets 10:14:55 2024-04-19 am EDT			5-day change	1st Jan Change
0.005 ^CAD	0.00%		0.00%	0.00%

2023	Lumiera Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	CI
2023	Lumiera Health Inc. Appoints Mr. Shawn Moniz to the Board of Directors	CI

Lumiera Health Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023

July 12, 2023 at 10:45 am EDT

Lumiera Health Inc. reported earnings results for the first quarter ended February 28, 2023. For the first quarter, the company reported sales was CAD 0.068585 million compared to CAD 0.144995 million a year ago. Net loss was CAD 0.083082 million compared to CAD 0.523233 million a year ago.

Latest news about Lumiera Health Inc.

Lumiera Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2023	23-10-27	CI
Lumiera Health Inc. Appoints Mr. Shawn Moniz to the Board of Directors	23-10-04	CI
Lumiera Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2023	23-08-04	CI
Lumiera Health Inc. Reports Earnings Results for the First Quarter Ended February 28, 2023	23-07-12	CI
Lumiera Health Inc. Reports Earnings Results for the Full Year Ended November 30, 2022	23-06-30	CI
Lumiera Health Inc. Auditor Raises 'Going Concern' Doubt	23-06-29	CI
Lumiera Health Inc. Announces Board Resignations	23-02-06	CI
Lumiera Health Inc. announced that it expects to receive CAD 0.6 million in funding	22-11-17	CI
Lumiera Health Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended August 31, 2022	22-10-31	CI
Lumiera Signs MOU with Natural Health Industry Company for Strategic Partnership, Licensing Agreement	22-09-28	MT
Lumiera Enters MOU with Natural Health Industry Leader for Strategic Partnership and Licensing Agreement	22-09-28	CI
Lumiera Health Inc. Reports Earnings Results for the Second Quarter and Six Months Ended May 31, 2022	22-07-27	CI
Lumiera Health Launches US Sales of Awaye Pain Relief Cream	22-06-09	MT
Lumiera Health Inc. Launches Awaye Pain Relief Cream in the US Market	22-06-09	CI
Lumiera Health Inc. Reports Sales Results for the Second Quarter 2022	22-06-01	CI
Lumiera Health Expands Retail Footprint of Awaye™ Pain Relief Across Quebec with Sobeys' Rachelle Béry	22-05-26	CI
Lumiera Health Seeks Health Canada Approval for a Menthol Version of Its Awaye Pain Relief Brand	22-05-04	MT
Lumiera Health Inc. Files New NPN Application with Health Canada to Extend Awaye Pain Relief Product Line	22-05-04	CI
Lumiera Health Inc. announced that it expects to receive CAD 0.15 million in funding from Fiducie De La Maison Bleue	22-05-03	CI
Lumiera Health Inc. Reports Earnings Results for the First Quarter Ended February 28, 2022	22-04-21	CI
Lumiera Health Expands Online Distribution, Says Sleep-Aids Now Available on Amazon and Well.ca	22-03-31	MT
Lumiera Health Inc Expands Online Distribution with Bazzzics™ Sleep-Aids on Amazon and Well.Ca	22-03-31	CI
Lumiera Health Signs Distribution Agreement to Launch Pain Relief Medication Awaye in Vietnam	22-03-24	MT
Lumiera Health Inc. Signs Distribution Agreement to Launch Awaye™ in Vietnam	22-03-24	CI
Lumiera Health Inc. Reports Earnings Results for the Full Year Ended November 30, 2021	22-03-22	CI

Chart Lumiera Health Inc.

Duration

Period

More charts

Company Profile

Lumiera Health Inc. is a Canada-based natural health products company. The principal business of the Company is that of selling natural and homeopathic products. The Company specializes in the development and commercialization of evidence-based botanical products for the healthcare industry. The Company sells both oral and topical botanical agents to help manage unmet medical needs through its Holizen Laboratories division. It is also developing and commercializing a portfolio of innovative solutions in high growth categories such as sleep-aids and pain management. Its product's portfolio categories such as topical pain relief, sleep, skin care, women's health, & infections. The Companyâs products and brands include Holizen, Awaye pain relief cream and Bazzzics. The Holizen portfolio has over 20 products that cover a range of therapeutic needs, including cardiovascular health; stress relief; bones, joints & muscle mobility; energy and immunity.

Sector

Pharmaceuticals

Calendar

2024-07-25 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
LUMIERA HEALTH INC.	0.00%	621K
ELI LILLY AND COMPANY	+25.83%	661B
NOVO NORDISK A/S	+27.00%	566B
JOHNSON & JOHNSON	-6.76%	352B
MERCK & CO., INC.	+20.34%	332B
ABBVIE INC.	+3.00%	283B
ASTRAZENECA PLC	+13.09%	231B
NOVARTIS AG	+5.46%	200B
ROCHE HOLDING AG	-9.61%	195B
AMGEN INC.	-6.26%	145B

Other Pharmaceuticals